Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells

Nature Immunology

Volumn 11, Issue 9, 2010, Pages 862-871

  Cardone, John ^a   Le Friec, Gaelle ^a   Vantourout, Pierre ^a,b   Roberts, Andrew ^a,b   Fuchs, Anja ^c   Jackson, Ian ^a   Suddason, Tesha ^a   Lord, Graham ^a   Atkinson, John P ^c   Cope, Andrew ^a,d   Hayday, Adrian ^a,b   Kemper, Claudia ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; COMPLEMENT; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LIGAND; MEMBRANE COFACTOR PROTEIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD46; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHO CELLS; COMPLEMENT ACTIVATING ENZYMES; CRICETINAE; CRICETULUS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; JURKAT CELLS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77955876612     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1917     Document Type: Article

References (50)

1. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
2. + T cells and accompanied by overproduction of IL-12, IFN-y and TNF-a. J. Immunol. 157, 798-805 (1996).
3. H1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7, 425-428 (2007).
4. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-defcient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
5. Franke, A. et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40, 1319-1323 (2008).
6. Hunter, C.A. et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316 (1997).
7. + T-cell subset inhibits antigen-specifc T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
8. Murphy, K.M. et al. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18, 451-494 (2000).
9. Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352 (2005).
10. H-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397 (2007).
11. H2) T cell clones and inhibits their antigen-specifc proliferation and cytokine production. J. Immunol. 150, 353-360 (1993).
12. Assenmacher, M., Schmitz, J. & Radbruch, A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-y and in interleukin-4-expressing cells. Eur. J. Immunol. 24, 1097-1101 (1994).
13. Windhagen, A., Anderson, D.E., Carrizosa, A., Williams, R.E. & Hafer, D.A. IL-12 induces human T cells secreting IL-10 with IFN-y. J. Immunol. 157, 1127-1131 (1996).
14. Gerosa, F. et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-y and interleukin-10. J. Exp. Med. 183, 2559-2569 (1996).
15. + T cell clones producing both interferon-y and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92, 224-234 (1999).
16. H1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-297 (2007).
17. H1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 (2007).
18. H1 cells. J. Exp. Med. 206, 1755-1767 (2009).
19. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388-392 (2003).
20. Kemper, C. & Atkinson, J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 7, 9-18 (2007).
21. Caudy, A.A., Reddy, S.T., Chatila, T., Atkinson, J.P. & Verbsky, J.W. CD25 defciency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119, 482-487 (2007).
22. Seya, T., Turner, J.R. & Atkinson, J.P. Purifcation and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163, 837-855 (1986).
23. Astier, A., Trescol-Biemont, M.C., Azocar, O., Lamouille, B. & Rabourdin-Combe, C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164, 6091-6095 (2000).
24. Zaffran, Y. et al. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167, 6780-6785 (2001).
25. Liszewski, M.K., Post, T.W. & Atkinson, J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9, 431-455 (1991).
26. Wang, G., Liszewski, M.K., Chan, A.C. & Atkinson, J.P. Membrane cofactor protein (MCP; CD46): isoform-specifc tyrosine phosphorylation. J. Immunol. 164, 1839-1846 (2000).
27. Astier, A.L. et al. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol. 184, 685-693 (2010).
28. Liu, J. et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201, 567-577 (2005).
29. Heeger, P.S. et al. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201, 1523-1530 (2005).
30. + T cells. Immunity 28, 425-435 (2008).
31. + T cells by streptococcal M protein. J. Immunol. 175, 677-684 (2005).
32. + T lymphocytes. Eur. J. Immunol. 34, 2439-2448 (2004).
33. Pennington, D.J. et al. Early events in the thymus affect the balance of effector and regulatory T cells. Nature 444, 1073-1077 (2006).
34. Glimcher, L.H. & Murphy, K.M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14, 1693-1711 (2000).
35. H17 T cells. Curr. Opin. Immunol. 19, 281-286 (2007).
36. H1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209-219 (2009).
37. Powell, J.D., Lerner, C.G., Ewoldt, G.R. & Schwartz, R.H. The-180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163, 6631-6639 (1999).
38. Li, Y. et al. SPAK kinase is a substrate and target of PKCθ in T-cell receptor-induced AP-1 activation pathway. EMBO J. 23, 1112-1122 (2004).
39. Delpire, E. & Gagnon, K.B. SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells. Biochem. J. 409, 321-331 (2008).
40. + T cells. J. Leukoc. Biol. 86, 1305-1310 (2009).
41. Carroll, M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 5, 981-986 (2004).
42. Morgan, B.P., Marchbank, K.J., Longhi, M.P., Harris, C.L. & Gallimore, A.M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 97, 171-179 (2005).
43. Friec, G.L. & Kemper, C. Complement: coming full circle. Arch. Immunol. Ther. Exp. (Warsz.) 57, 393-407 (2009).
44. Kerekes, K., Prechl, J., Bajtay, Z., Jozsi, M. & Erdei, A. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specifc T cells. Int. Immunol. 10, 1923-1930 (1998).
45. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
46. Astier, A.L., Meiffren, G., Freeman, S. & Hafer, D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116, 3252-3257 (2006).
47. Collins, M. Tipping the balance in autoimmune disease. Genome Biol. 8, 317 (2007).
48. Meiler, F. et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205, 2887-2898 (2008).
49. Rubtsov, Y.P. et al. Regulatory T cell-derived interleukin-10 limits infammation at environmental interfaces. Immunity 28, 546-558 (2008).
50. White, J. et al. Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli. Protein Sci. 13, 2406-2415 (2004).